Overview
Takashi Mochizuki practices in Kanazawa, Japan. Mr. Mochizuki is rated as an Experienced expert by MediFind in the treatment of Microscopic Polyangiitis. His top areas of expertise are Ringworm, Athlete's Foot, Fungal Nail Infection, and Kerion Celsi.
His clinical research consists of co-authoring 112 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Microscopic Polyangiitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Athlete's FootMr. Mochizuki isDistinguished. Learn about Athlete's Foot.
- RingwormMr. Mochizuki isDistinguished. Learn about Ringworm.
- Advanced
- Fungal Nail InfectionMr. Mochizuki isAdvanced. Learn about Fungal Nail Infection.
- Kerion CelsiMr. Mochizuki isAdvanced. Learn about Kerion Celsi.
- SporotrichosisMr. Mochizuki isAdvanced. Learn about Sporotrichosis.
- Experienced
- AcrospiromaMr. Mochizuki isExperienced. Learn about Acrospiroma.
- Aplasia Cutis CongenitaMr. Mochizuki isExperienced. Learn about Aplasia Cutis Congenita.
- ArthritisMr. Mochizuki isExperienced. Learn about Arthritis.
- CellulitisMr. Mochizuki isExperienced. Learn about Cellulitis.
- ChromoblastomycosisMr. Mochizuki isExperienced. Learn about Chromoblastomycosis.
- Clouston SyndromeMr. Mochizuki isExperienced. Learn about Clouston Syndrome.